Test Bank for Ruppel’s Manual of Pulmonary Function Testing
| | | | | | | |
12th Edition, By Mottram
| | | |
Chapter 1 - 13 Updated
| | | | |
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
| | | | | | | |
MULTIPLE |CHOICE
1. Who |first |popularized |spirometry |for |the |evaluation |of |pulmonary |function?
a. August |and |Marie |Krogh
b. Alvan |Barach
c. John |Severinghaus
d. John |Hutchinson
ANS: |D
Hutchinson |popularized |the |concept |of |using |VC |to |assess |lung |function, |and |the |names |he
|gave |to |several |other |lung |compartments |are |still |used |today.
DIF: 1 REF: p. |2 OBJ: None | MSC: |NBRC: |None
2. Which |of |the |following |are |indications |for |performing |spirometry?
1. Assess |the |risk |of |lung |resection.
2. Determine |the |response |to |bronchodilator |therapy.
3. Assess |the |severity |of |restrictive |lung |disease.
4. Quantify |the |extent |of |COPD.
a. 1 | and | 4
b. 2 | and | 3
c. 1 |, |2, |and | 4
d. 2 |, |3, |and | 4
ANS: |C
Spirometry |cannot |assess |severity |of |restriction; |for |that |you |need |to |measure |lung |volumes
|( |see |Box |1-2, |Chapter | 1).
DIF: 1 REF: p. |7 OBJ: EL-2 MSC: |NBRC: |None
,3. The |main |indication |for |the |measurement |of |lung |volumes |is |to |do |which |of |the |following?
a. Diagnose |or |assess |the |severity |of |restriction.
b. Evaluate |the |severity |of |pulmonary |hypertension.
c. Determine |the |level |of |cardiopulmonary |fitness.
d. Assess |the |risk |of |abdominal |surgical |procedures.
ANS: |A
The |most |common |reason |for |measuring |lung |volumes |is |to |identify |restrictive |lung
disease. |DIF:
| 1 REF: p. |35 OBJ: EL-2 MSC: |NBRC: |None
4. DLCO |measurements |may |be |indicated |to |evaluate |pulmonary |involvement |in |which |of
|the |following |systemic |diseases?
a. Asthma
b. Sarcoidosis
c. Exertional |hypoxemia
, Stuvia.com |- |The |Marketplace |to |Buy |and |Sell |your |Study |Material
d. Guillain-Barré |syndrome
ANS: |B
Sarcoidosis |is |the |only |systemic |disease |listed |that |affects |gas |exchange.
|DIF: |1 |REF: |p. |9 || |p. |19 || |p. |21 || |p. |35 |OBJ: |EL-2 |MSC: |NBRC: |None
5. Blood |gas |analysis |is |used |with |patients |with |COPD |to |do |which |of
|the |following?
a. Monitor |airway |responsiveness.
b. Determine |level |of |cardiopulmonary |fitness.
c. Detect |pulmonary |hypertension.
d. Assess |need |for |supplementary |O2.
ANS: |D
Blood |gas |analysis |is |most |commonly |used |to |determine |the |need |for |supplemental
|oxygen |and |to |manage |patients |who |require |ventilatory |support.
DIF: 2 REF: p. |15 OBJ: EL-1
|MSC: |NBRC: |CPFT |2A-2
6. Which |of |the |following |cause |emphysema?
1. 1- |Antitrypsin |deficiency
2. Exposure |to |environmental |pollutants
3. Radiation |therapy
4. Cigarette |smoking
a. 1 | and | 2
b. 3 | and | 4
c. 1 |, |2, |and | 4
d. 2 |, |3, |and | 4
ANS: |C
Emphysema |is |caused |primarily |by |cigarette |smoking. |Some |emphysema |is |caused |by |the
|absence |of |a |protective |enzyme. |Chronic |exposure |to |environmental |pollutants |can |also
|contribute |to |the |development |of |emphysema.
DIF: 1 REF: p. |11 OBJ: EL-3 || |AL-2 MSC: |NBRC: |None
7. An |adult |patient |complains |of |chest |tightness |and |cough |whenever |he |jogs |in |cold
|weather. |These |symptoms |are |consistent |with |which |of |the |following?
a. Cystic |fibrosis
b. Asthma
c. Pulmonary |hypertension
d. Idiopathic |pulmonary |fibrosis
|
| | | | | | | |
12th Edition, By Mottram
| | | |
Chapter 1 - 13 Updated
| | | | |
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
| | | | | | | |
MULTIPLE |CHOICE
1. Who |first |popularized |spirometry |for |the |evaluation |of |pulmonary |function?
a. August |and |Marie |Krogh
b. Alvan |Barach
c. John |Severinghaus
d. John |Hutchinson
ANS: |D
Hutchinson |popularized |the |concept |of |using |VC |to |assess |lung |function, |and |the |names |he
|gave |to |several |other |lung |compartments |are |still |used |today.
DIF: 1 REF: p. |2 OBJ: None | MSC: |NBRC: |None
2. Which |of |the |following |are |indications |for |performing |spirometry?
1. Assess |the |risk |of |lung |resection.
2. Determine |the |response |to |bronchodilator |therapy.
3. Assess |the |severity |of |restrictive |lung |disease.
4. Quantify |the |extent |of |COPD.
a. 1 | and | 4
b. 2 | and | 3
c. 1 |, |2, |and | 4
d. 2 |, |3, |and | 4
ANS: |C
Spirometry |cannot |assess |severity |of |restriction; |for |that |you |need |to |measure |lung |volumes
|( |see |Box |1-2, |Chapter | 1).
DIF: 1 REF: p. |7 OBJ: EL-2 MSC: |NBRC: |None
,3. The |main |indication |for |the |measurement |of |lung |volumes |is |to |do |which |of |the |following?
a. Diagnose |or |assess |the |severity |of |restriction.
b. Evaluate |the |severity |of |pulmonary |hypertension.
c. Determine |the |level |of |cardiopulmonary |fitness.
d. Assess |the |risk |of |abdominal |surgical |procedures.
ANS: |A
The |most |common |reason |for |measuring |lung |volumes |is |to |identify |restrictive |lung
disease. |DIF:
| 1 REF: p. |35 OBJ: EL-2 MSC: |NBRC: |None
4. DLCO |measurements |may |be |indicated |to |evaluate |pulmonary |involvement |in |which |of
|the |following |systemic |diseases?
a. Asthma
b. Sarcoidosis
c. Exertional |hypoxemia
, Stuvia.com |- |The |Marketplace |to |Buy |and |Sell |your |Study |Material
d. Guillain-Barré |syndrome
ANS: |B
Sarcoidosis |is |the |only |systemic |disease |listed |that |affects |gas |exchange.
|DIF: |1 |REF: |p. |9 || |p. |19 || |p. |21 || |p. |35 |OBJ: |EL-2 |MSC: |NBRC: |None
5. Blood |gas |analysis |is |used |with |patients |with |COPD |to |do |which |of
|the |following?
a. Monitor |airway |responsiveness.
b. Determine |level |of |cardiopulmonary |fitness.
c. Detect |pulmonary |hypertension.
d. Assess |need |for |supplementary |O2.
ANS: |D
Blood |gas |analysis |is |most |commonly |used |to |determine |the |need |for |supplemental
|oxygen |and |to |manage |patients |who |require |ventilatory |support.
DIF: 2 REF: p. |15 OBJ: EL-1
|MSC: |NBRC: |CPFT |2A-2
6. Which |of |the |following |cause |emphysema?
1. 1- |Antitrypsin |deficiency
2. Exposure |to |environmental |pollutants
3. Radiation |therapy
4. Cigarette |smoking
a. 1 | and | 2
b. 3 | and | 4
c. 1 |, |2, |and | 4
d. 2 |, |3, |and | 4
ANS: |C
Emphysema |is |caused |primarily |by |cigarette |smoking. |Some |emphysema |is |caused |by |the
|absence |of |a |protective |enzyme. |Chronic |exposure |to |environmental |pollutants |can |also
|contribute |to |the |development |of |emphysema.
DIF: 1 REF: p. |11 OBJ: EL-3 || |AL-2 MSC: |NBRC: |None
7. An |adult |patient |complains |of |chest |tightness |and |cough |whenever |he |jogs |in |cold
|weather. |These |symptoms |are |consistent |with |which |of |the |following?
a. Cystic |fibrosis
b. Asthma
c. Pulmonary |hypertension
d. Idiopathic |pulmonary |fibrosis
|
